Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

P3 Health Partners (PIII) EBITDA Margin (2020 - 2025)

P3 Health Partners (PIII) has disclosed EBITDA Margin for 6 consecutive years, with 9588.38% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBITDA Margin fell 955883.0% year-over-year to 9588.38%, compared with a TTM value of 34.66% through Sep 2025, down 833.0%, and an annual FY2024 reading of 21.21%, up 1213066.0% over the prior year.
  • EBITDA Margin was 9588.38% for Q3 2025 at P3 Health Partners, down from 7319.65% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 6.73% in Q2 2024 and bottomed at 11082.1% in Q1 2024.
  • Average EBITDA Margin over 5 years is 1798.25%, with a median of 26.74% recorded in 2022.
  • The sharpest move saw EBITDA Margin crashed -1106614bps in 2024, then surged 1107205bps in 2025.
  • Year by year, EBITDA Margin stood at 48.98% in 2021, then tumbled by -324bps to 207.56% in 2022, then skyrocketed by 92bps to 15.96% in 2023, then tumbled by -133bps to 37.23% in 2024, then crashed by -25654bps to 9588.38% in 2025.
  • Business Quant data shows EBITDA Margin for PIII at 9588.38% in Q3 2025, 7319.65% in Q2 2025, and 10.04% in Q1 2025.